APA (7th ed.) Citation

Abdel-Wahab, N. D., Kabil, M. F., El-Sherbiny, I. M., Salama, M. F., El-Sayed, G., & El-Sherbini, E. (2024). Potential anticancer effect of free and nanoformulated Deferasirox for breast cancer treatment: In-vitro and in-vivo evaluation. Drug Development & Industrial Pharmacy, 50(3), 223. https://doi.org/10.1080/03639045.2024.2314189

Chicago Style (17th ed.) Citation

Abdel-Wahab, Nadeen Diaa, Mohamed Fawzi Kabil, Ibrahim M. El-Sherbiny, Mohamed F. Salama, Gehad El-Sayed, and El-Said El-Sherbini. "Potential Anticancer Effect of Free and Nanoformulated Deferasirox for Breast Cancer Treatment: In-vitro and In-vivo Evaluation." Drug Development & Industrial Pharmacy 50, no. 3 (2024): 223. https://doi.org/10.1080/03639045.2024.2314189.

MLA (9th ed.) Citation

Abdel-Wahab, Nadeen Diaa, et al. "Potential Anticancer Effect of Free and Nanoformulated Deferasirox for Breast Cancer Treatment: In-vitro and In-vivo Evaluation." Drug Development & Industrial Pharmacy, vol. 50, no. 3, 2024, p. 223, https://doi.org/10.1080/03639045.2024.2314189.